Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1994 | 12-1993 | 09-1993 | 06-1993 | 03-1993 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,158 | 2,151 | 2,240 | 1,948 | 1,608 |
| Marketable Securities | 341 | 487 | 499 | 440 | 440 |
| Receivables | 595 | 755 | 459 | 550 | 691 |
| Other current assets | 352 | 300 | 462 | 374 | 244 |
| TOTAL | $3,445 | $3,694 | $3,660 | $3,312 | $2,983 |
| Non-Current Assets | |||||
| Investments And Advances | 311 | 303 | 302 | 294 | 1,038 |
| Other Non-Current Assets | 1,469 | 1,529 | 1,604 | 1,662 | 1,859 |
| TOTAL | $1,780 | $1,831 | $1,905 | $1,955 | $2,898 |
| Total Assets | $5,854 | $6,084 | $6,077 | $5,719 | $6,580 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 316 | 348 | 291 | 329 | 370 |
| Accrued Expenses | 589 | 716 | 775 | 695 | 627 |
| TOTAL | $1,007 | $1,064 | $1,066 | $1,024 | $997 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 598 | 573 | 578 | 562 | 476 |
| TOTAL | $598 | $573 | $578 | $562 | $663 |
| Total Liabilities | $1,180 | $1,216 | $1,211 | $1,146 | $1,347 |
| Shareholders' Equity | |||||
| Common Shares | 58 | 58 | 58 | 57 | 57 |
| Retained earnings | -19,917 | -19,719 | -19,674 | -19,448 | -18,618 |
| Other shareholders' equity | 61 | 60 | 61 | 60 | 61 |
| TOTAL | $4,250 | $4,447 | $4,433 | $4,133 | $4,920 |
| Total Liabilities And Equity | $5,430 | $5,663 | $5,644 | $5,280 | $6,266 |